Keyphrases
Emergency Department
100%
Drug-related Problems
24%
Delirium
24%
Emergency Patients
23%
Acute Decompensated Heart Failure
23%
Anticholinergic Burden
17%
ST-elevation Myocardial Infarction (STEMI)
15%
Frailty
14%
Emergency Room
14%
Frail Elderly
13%
Constipation
12%
At Discharge
11%
Risk Factors
11%
Cardiac Transplantation
11%
Primary PCI
11%
Intestinal Inflammation
11%
COVID-19
11%
Clinical Course
11%
Clinical Characteristics
11%
Piperacillin-tazobactam
11%
Urinary Tract Infection
11%
Oral Anticoagulants
11%
Pharmacy Medicines
11%
Pharmacist Care
11%
Septic Patients
11%
Ictus
11%
Hospital Emergency Department
11%
Emergency Service
10%
Escherichia Coli
9%
Direct Oral Anticoagulants
9%
Extended Infusion
9%
National Institutes of Health Stroke Scale (NIHSS)
9%
Atrial Fibrillation
8%
Hospitalized Patients
8%
Probability of Target Attainment
8%
Retrospective Observational Study
8%
Multidrug-resistant Bacteria
8%
Multivariate Analysis
8%
Activation Time
8%
First Medical Contact
7%
Transplantation
7%
Older Adults
7%
Anticoagulants
7%
Therapeutic Management
7%
Vitamin K Antagonists
7%
Modified Rankin Scale
7%
Care Program
7%
Interdisciplinary Programs
7%
Ischemic Stroke
7%
Brain-dead Donor
7%
Medicine and Dentistry
Emergency Department
79%
Apoplexy
18%
Drug Therapy
16%
Triage
14%
Consultation
13%
Comorbidity
13%
Heart Transplantation
13%
Delirium
12%
Percutaneous Coronary Intervention
12%
Emergency Medicine
12%
Decompensated Heart Failure
11%
Cerebrovascular Disease
11%
COVID-19
11%
Hospital Pharmacy
11%
Antithrombotic
11%
Mortality Rate
10%
Nurse
10%
Electrocardiogram
9%
Observational Study
9%
Infection
8%
Retrospective Study
7%
Action Potential
7%
Diseases
7%
National Institutes of Health Stroke Scale
7%
Brain Ischemia
7%
Cerebral Hemorrhage
7%
Tocilizumab
7%
D-Dimer
7%
Direct Oral Anticoagulant
7%
Pharmaceutical Care
6%
Clinical Trial
6%
Emergency Care
6%
Digestive System Hemorrhage
6%
Risk Stratification
6%
Atrial Fibrillation
6%
Health System
6%
Kidney Transplantation
5%
Frailty
5%
Heart Muscle Injury
5%
Programmed Cell Death
5%
Escherichia coli
5%
Cardiovascular Risk
5%
Acute Pancreatitis
5%
Muscle Cell
5%
Alteplase
5%
Door-to-Balloon
5%
Backache
5%
Ornithine Transcarbamylase Deficiency
5%
Pulmonary Embolism
5%
Hospital Mortality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Comorbidity
18%
Cerebrovascular Accident
17%
Cholinergic Receptor Blocking Agent
17%
Retrospective Study
17%
Observational Study
11%
Enteritis
11%
Cerebrovascular Disease
11%
Anticoagulant Agent
11%
Constipation
11%
Piperacillin Plus Tazobactam
11%
Urinary Tract Infection
11%
Hospital Pharmacy
11%
Escherichia coli
10%
Inflammation
9%
Mortality Rate
9%
Disease
9%
Pharmacotherapy
9%
Infection
8%
D Dimer
7%
Tocilizumab
7%
Pharmacodynamics
6%
Pharmacokinetics
6%
Survival Rate
6%
Croton Oil
6%
Hospital Mortality
5%
Frailty
5%
Gangrene
5%
Backache
5%
Ornithine Transcarbamylase Deficiency
5%
Metformin
5%
Lung Embolism
5%
Functional Status
5%
Coronavirinae
5%
Delirium
5%
Heart Infarction
5%
Morphine
5%
Rendu Osler Weber Disease
5%
Congestive Heart Failure
5%
Syndrome
5%
Abdominal Pain
5%
Minimum Inhibitory Concentration
5%
Lactic Acidosis
5%
Meningitis
5%
Cefepime
5%
Acute Heart Infarction
5%
Alpha Adrenergic Receptor Stimulating Agent
5%
Somnolence
5%
Cardiovascular Risk
5%
Antiinfective Agent
5%
Base
5%